Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Big-Cap Biotech Worries Lead Sector Down
TheStreet.com
Tuesday, October 27, 2009 - 8:20am
tags:
biotech, Amgen, Celgene, Gilead Sciences, Genzyme, Biomarin, ONYX Pharmaceuticals
Lilly May Face A Backlash Over Diabetes Report
Pharmalot
Tuesday, October 27, 2009 - 8:19am
tags:
diabetes, Eli Lilly
Medivation Lands Partner for Prostate Cancer Drug
TheStreet.com
Tuesday, October 27, 2009 - 8:16am
tags:
prostate cancer, partnerships, Medivation, Astellas
Pfizer Unit’s Prempro Punitive Damages Verdict Remains Secret
Bloomberg
Tuesday, October 27, 2009 - 8:15am
tags:
Prempro, Pfizer, Wyeth
Genmab Surges After FDA Clears Cancer Drug Shared With Glaxo
Bloomberg
Tuesday, October 27, 2009 - 8:14am
tags:
GSK, Genmab, leukemia, Arzerra
Keryx Biopharmaceuticals' Next Price Movers Will Be Trial News
Seeking Alpha
Tuesday, October 27, 2009 - 8:14am
tags:
Keryx
BioMarin to buy Huxley Pharmaceuticals
Bizjournals.com
Monday, October 26, 2009 - 8:55pm
tags:
Huxley Pharmaceuticals, Biomarin, M&A
Icagen exercise-induced asthma drug senicapoc trial fails; company plans to halt development
Yahoo/AP
Monday, October 26, 2009 - 8:54pm
tags:
Icagen, asthma, senicapoc, drug trials
When FDA Fails to Follow-Up On Rapid Drug Approvals
WSJ Online
Monday, October 26, 2009 - 6:17pm
tags:
FDA, drug approvals
Unusual Call Volume in Merck: Options
TheStreet.com
Monday, October 26, 2009 - 6:08pm
tags:
Merck, options
Slow diagnosis hampers uptake of fibromyalgia drugs
Medical Marketing and Media
Monday, October 26, 2009 - 6:06pm
tags:
fibromyalgia, Pfizer, Lyrica, Eli Lilly, Cymbalta
Whatever Tysabri Outcome, Biogen Idec Should Survive
BNET Pharma
Monday, October 26, 2009 - 6:05pm
tags:
Tysabri, MS, multiple sclerosis, Biogen Idec, Elan
Vertex Pharma books larger 3rd-quarter loss as collaboration revenue falls, costs increase
Yahoo/AP
Monday, October 26, 2009 - 6:04pm
tags:
Vertex Pharmaceuticals, earnings
Earnings Preview: GlaxoSmithKline Q3 earns seen up
Yahoo/AP
Monday, October 26, 2009 - 6:02pm
tags:
GSK, earnings
Abbott Laboratories: Dividend Stock Analysis
Seeking Alpha
Monday, October 26, 2009 - 12:02pm
tags:
Abbott Laboratories, dividends
Pfizer Produces Snapshot of Combined Company: $66B in Revenue; Only $2.2B in Cash
BNET Pharma
Monday, October 26, 2009 - 11:59am
tags:
Pfizer, Wyeth, M&A, earnings
Effient and Onglyza Start Slow—And That May Not Be A Bad Thing
InVivo
Monday, October 26, 2009 - 11:57am
tags:
Effient, Onglyza, diabetes, Eli Lilly, Bristol-Myers Squibb, Daiichi Sankyo, Prasugrel
FDA doesn't act on post-marketing data
Fierce Pharma
Monday, October 26, 2009 - 11:56am
tags:
post-marketing data, FDA
Shire gets boost as FDA backs Vyvanse exclusivity
Reuters
Monday, October 26, 2009 - 11:55am
tags:
Shire, FDA, Vyvanase, ADHD
[video] Vivus CEO on Diet Drug
CNBC
Monday, October 26, 2009 - 11:38am
tags:
Vivus, obesity, Qnexa, Pharma CEOs, Leland WIlson

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.